← All trials
NCT05580510
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 6, 2023
- Primary completion
- Jul 28, 2023
- Completion date
- Mar 29, 2024
- First posted
- Oct 14, 2022
- Last posted
- Nov 2, 2022
- Enrollment
- 160
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Instituto Nacional de Cardiologia Ignacio ChavezLead sponsor
- Boehringer IngelheimCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.